Image 1
Sildenafil Tablet, Film Coated
Product Images NDC 0093-5341
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 0093-5341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Sildenafil Tablets Usp 50 mg, 30s Label (Image 10)
This is a description of a medication with the NDC code 0093-5342-56. The medication is Sildenafil tablets USP, with a strength of 50mg. The usual dosage information can be found on the package insert. The medicine should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) and kept in a child-resistant container. The medication is manufactured by Pliva Hrvatska d.o.0 in Zagreb, Croatia and is distributed by Teva Pharmaceuticals USA, Inc in North Wales, PA 19454.*
Sildenafil Tablets Usp 100 mg, 30s Label (Image 11)
This is a description for medication with the NDC code 0093-5343-56. The medication is Sildenafil, which comes in tablets with a strength of 100 mg. The tablets are film-coated and contain sildenafil citrate. The usual dosage can be found in the package insert. The medication should be stored in a controlled room temperature and in a light-resistant, child-resistant container. The manufacturer is Pliva Hrvatska d.0.0 in Croatia, and it is manufactured for Teva Pharmaceuticals USA, Inc. There are 30 tablets in the container.*
Image 2
Image 3
Image 4
This is a tabular representation of the change in systolic blood pressure (SBP) measured in millimeters of mercury (mmHg) over time postdose for two different treatments. The first treatment group received doxazosin and a placebo, while the second treatment group received doxazosin and 50 mg of sildenafil.*
Image 5
Image 6
Image 7
Image 8
This is a data table showing the percentage of patients reporting improvement in different treatment groups. The treatments being compared are placebo, and different dosages of a drug called Sildenafil. The data indicates that 82% of patients taking 100mg of Sildenafil reported improvement, compared to only 7% of patients taking placebo. The overall treatment was statistically significant (p < 0.0001).*
Image 9
This is a description for a medication containing sildenafil citrate, with a recommended dosage provided in the package insert. It should be stored in a controlled room temperature of 20°C to 25°C and kept out of reach of children. The medication is manufactured in Croatia by Pliva Hrvatska and distributed by Teva Pharmaceuticals USA. The provided text includes a GTIN code and product code.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
